MiNK Therapeutics, Inc. (INKT)
Nasdaq · Biological Products, (No Diagnostic Substances) · Inc. DE
What they're doing
Not enough recent activity to summarise.
Signals, last 12 months
- Material 8-K filingFiled 8-K disclosing director or officer change
- Material 8-K filingFiled 8-K disclosing director or officer change
- Material 8-K filingFiled 8-K disclosing director or officer change
Insider transactions
| Date | Insider | Role | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-04 | Ryan Barbara | director | S | 1,000 | 12.8 | $12,800 |
| 2026-06-04 | Ryan Barbara | director | S | 500 | 12.68 | $6,340 |
| 2026-06-01 | Holcomb John Bradley | director | A | 1,091 | 12.38 | $13,507 |
| 2026-06-01 | Ryan Barbara | director | A | 1,434 | 12.38 | $17,753 |
| 2026-06-01 | Corvese Brian | director | A | 1,444 | 12.38 | $17,877 |
| 2026-06-01 | Behner Peter | director | A | 1,313 | 12.38 | $16,255 |
| 2026-06-01 | WIINBERG ULF | director | A | 1,131 | 12.38 | $14,002 |
| 2026-03-10 | Ryan Barbara | director | S | 500 | 15.3 | $7,650 |
| 2026-03-10 | Ryan Barbara | director | S | 500 | 15.57 | $7,785 |
| 2026-03-10 | Ryan Barbara | director | S | 300 | 15.28 | $4,584 |
| 2026-03-09 | Ryan Barbara | director | S | 200 | 10.17 | $2,034 |
| 2026-03-02 | Holcomb John Bradley | director | A | 1,239 | 10.9 | $13,505 |
| 2026-03-02 | Ryan Barbara | director | A | 1,629 | 10.9 | $17,756 |
| 2026-03-02 | Corvese Brian | director | A | 1,640 | 10.9 | $17,876 |
| 2026-03-02 | Behner Peter | director | A | 1,491 | 10.9 | $16,252 |
| 2026-03-02 | WIINBERG ULF | director | A | 1,285 | 10.9 | $14,007 |
| 2026-03-02 | Ryan Barbara | director | S | 100 | 10.83 | $1,083 |
| 2026-02-27 | Ryan Barbara | director | S | 400 | 10.86 | $4,344 |
| 2026-01-02 | Buell Jennifer | officer | F | 10,024 | 11.12 | $111,467 |
| 2026-01-02 | Buell Jennifer | officer | A | 31,474 | 11.12 | $349,991 |
| 2025-12-01 | Corvese Brian | director | A | 1,612 | 11.09 | $17,877 |
| 2025-12-01 | Behner Peter | director | A | 1,466 | 11.09 | $16,258 |
| 2025-12-01 | Holcomb John Bradley | director | A | 1,128 | 11.09 | $12,510 |
| 2025-12-01 | Ryan Barbara | director | A | 1,601 | 11.09 | $17,755 |
| 2025-12-01 | Kadlec Robert Peter | director | A | 1,218 | 11.09 | $13,508 |
| 2025-12-01 | WIINBERG ULF | director | A | 1,263 | 11.09 | $14,007 |
| 2025-09-09 | Buell Jennifer | officer | F | 5,351 | 15.36 | $82,191 |
| 2025-09-09 | Buell Jennifer | officer | A | 18,229 | 15.36 | $279,997 |
| 2025-09-02 | WIINBERG ULF | director | A | 1,011 | 13.86 | $14,012 |
| 2025-09-02 | Kadlec Robert Peter | director | A | 975 | 13.86 | $13,514 |
| 2025-09-02 | Ryan Barbara | director | A | 1,281 | 13.86 | $17,755 |
| 2025-09-02 | Corvese Brian | director | A | 1,290 | 13.86 | $17,879 |
| 2025-09-02 | Behner Peter | director | A | 1,173 | 13.86 | $16,258 |
| 2025-06-02 | Behner Peter | director | A | 2,267 | 7.17 | $16,254 |
| 2025-06-02 | WIINBERG ULF | director | A | 1,953 | 7.17 | $14,003 |
| 2025-06-02 | Corvese Brian | director | A | 2,494 | 7.17 | $17,882 |
| 2025-06-02 | Kadlec Robert Peter | director | A | 1,883 | 7.17 | $13,501 |
| 2025-06-02 | Ryan Barbara | director | A | 2,476 | 7.17 | $17,753 |
| 2025-03-03 | Corvese Brian | director | A | 2,033 | 8.79 | $17,870 |
| 2025-03-03 | Ryan Barbara | director | A | 2,019 | 8.79 | $17,747 |
| 2025-03-03 | WIINBERG ULF | director | A | 1,593 | 8.79 | $14,002 |
| 2025-03-03 | Behner Peter | director | A | 1,849 | 8.79 | $16,253 |
| 2025-03-03 | Kadlec Robert Peter | director | A | 1,536 | 8.79 | $13,501 |
| 2024-12-01 | WIINBERG ULF | director | A | 20,476 | 0.73 | $14,947 |
| 2024-12-01 | Behner Peter | director | A | 20,987 | 0.73 | $15,321 |
| 2024-12-01 | Corvese Brian | director | A | 24,400 | 0.73 | $17,812 |
| 2024-12-01 | Ryan Barbara | director | A | 24,229 | 0.73 | $17,687 |
| 2024-12-01 | Kadlec Robert Peter | director | A | 12,286 | 0.73 | $8,969 |
| 2024-09-03 | Corvese Brian | director | A | 21,802 | 0.82 | $17,878 |
| 2024-09-03 | WIINBERG ULF | director | A | 18,295 | 0.82 | $15,002 |
Federal contracts
No federal contract actions on record for this recipient mapping.
Lobbying
No federal lobbying filings on record for this client mapping.
Public attention
No Wikipedia pageview data linked to this company.